Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197853) titled 'Clinical Efficacy and Safety of Microwave Ablation Combined With Huaier Granules in Patients With Inoperable Stage IA Non-Small Cell Lung Cancer: A Prospective, Single-Center, Randomized Controlled Clinical Trial' on Sept. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Xin Ye
Condition:
Non-small Cell Lung Cancer (NSCLC)
Huaier Granules
Microwave Ablation
Intervention:
Drug: Huaier Granule
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October ...